forstoringsglas

Search results

Vinge advises Axel Johnson in connection with Dustin’s rights offering

Dustin AB (publ) carries out a rights offering of approximately SEK 1,750 million, fully guaranteed by Axel Johnson.
October 16, 2023

Vinge advises Studentbostäder i Norden AB (publ) in connection with its rights issue and written procedure in relation to its notes

Vinge is advising Studentbostäder i Norden AB (publ), a real estate company whose shares are listed on Nasdaq First North Premier Growth Market, in connection with a fully guaranteed rights issue amounting to a total of SEK 331 million before deduction of transaction costs and the amendments to the terms and conditions of the company’s outstanding green 2021/2024 notes with ISIN SE0015960802 (the “Notes”) by way of a written procedure.
October 13, 2023

Vinge has advised Egetis Therapeutics in connection with a combined financing comprising an equity private placement and debt financing

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), an innovative and integrated pharmaceutical company focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment, listed on Nasdaq Stockholm, in connection with a combined financing comprising a SEK 172 million equity private placement and a SEK 290 million debt financing.
October 13, 2023

Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge has advised Flat Capital in connection with its rights issue

Vinge has advised Flat Capital in connection with its rights issue, which provides Flat Capital with proceeds of approximately SEK 153 million before deduction of transaction costs.
September 07, 2023

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with its newly established subsidiary SBB Residential Property AB entering into a capital raise agreement with an investment fund managed by Morgan Stanley Real Estate Investing (“MSREI”).

Pursuant to the agreement, SBB Residential Property AB will issue SEK 2.36 billion of preference shares to MSREI. The preference shares will be issued by an entity to be named SBB Residential Property AB forming a new group within SBB.
July 25, 2023

Vinge advises Axel Johnson on its public offer for Dustin

Axel Johnson AB, through its wholly-owned subsidiary, AxMedia AB, has made a public mandatory offer for all shares in Dustin Group AB (publ). The offer values all shares in Dustin at approximately SEK 3.2 billion.
July 02, 2023

Vinge has advised Re:NewCell in connection with a directed share issue

Vinge has advised Re:NewCell, a textile-to-textile recycling company listed on Nasdaq First North Premier Growth Market, in connection with a directed share issue whereby the company raised proceeds of approximately SEK 240 million before issue costs.
June 30, 2023

Vinge represents Bergs Timber AB (publ) in the acquisition of Hedlunda Holding AB

Bergs Timber AB (publ) (“Bergs”) has today acquired all shares in Hedlunda Holding AB (“Hedlunda”). Hedlunda is a state-of-the-art manufacturer of wooden furniture and components with production facilities in Sweden (Lycksele) and Poland (Skoczów).
June 30, 2023

Vinge has advised Vicore Pharma Holding AB (publ) in connection with directed share issuances

Vinge has advised Vicore Pharma Holding AB (publ) in connection with directed share issuances, whereby Vicore Pharma receives gross proceeds of SEK 500 million.
June 12, 2023

Vinge advises Symrise on its mandatory bid for Swedencare

Symrise AG has made a public mandatory bid for all shares in Swedencare AB (publ).
June 07, 2023

Vinge advises IBT in connection with rights offering

Vinge advises Infant Bacterial Therapeutics AB (publ) in connection with its rights offering of approximately SEK 100 million.
May 19, 2023

Vinge is advising Xspray Pharma in connection with its rights issue of units

Through the rights issue of units, Xspray is expected to receive approximately SEK 300 million, with two warrant series approximately amounting together up to an additional SEK 300 million upon full exercise.
May 04, 2023

Vinge advises Yubico in the merger with ACQ Bure  

ACQ Bure AB, a Swedish acquisition company (Special Purpose Acquisition Company) listed on Nasdaq Stockholm and Yubico AB have signed a merger agreement and adopted a joint merger plan to combine ACQ and Yubico.
April 20, 2023

Vinge has advised CTEK in connection with its rights issue  

Vinge has advised CTEK AB (publ) on a fully guaranteed rights issue, which will provide CTEK with issue proceeds of approximately SEK 350 million before deduction of transaction costs.
March 29, 2023
Previous Next